JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120764

Aripiprazole, Partial dopamine D2 agonist

Be the first to review this product! Submit a review

|

(0 Publication)

MW 448.39 g/mol, Purity >99%. Partial dopamine D2 agonist. Ki (nM) values are 265 (D1), 0.34 (D2), 0.8 (D3), 44 (D4), 1.7 (5-HT1A), 3.4 (5-HT2A), 15 (5-HT2C), 214 (5-HT6), 39 (5-HT7), 57 (α1), 791 (α2), 61 (H1) and >1000 (M1). Antipsychotic and antidepressant activity. Centrally active following oral administration.
1 Images
Chemical Structure - Aripiprazole, Partial dopamine D2 agonist (AB120764)
  • Chemical Structure

Lab

Chemical Structure - Aripiprazole, Partial dopamine D2 agonist (AB120764)

2D chemical structure image of ab120764, Aripiprazole, Partial dopamine D2 agonist

Key facts

CAS number

129722-12-9

Purity

>99%

Form

Solid

form

Molecular weight

448.39 g/mol

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Biological description

Partial dopamine D2 agonist. Ki (nM) values are 265 (D1), 0.34 (D2), 0.8 (D3), 44 (D4), 1.7 (5-HT1A), 3.4 (5-HT2A), 15 (5-HT2C), 214 (5-HT6), 39 (5-HT7), 57 (α1), 791 (α2), 61 (H1) and >1000 (M1). Antipsychotic and antidepressant activity. Centrally active following oral administration.

IUPAC Name

7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com